Literature DB >> 7854022

Visualization of superior mesenteric lymph nodes by the combined oral and intravenous administration of the ultrasmall superparamagnetic iron oxide, AMI-227.

J M Rogers1, J Lewis, L Josephson.   

Abstract

Superior mesentric lymph nodes which lie as a chain near the small intestine are difficult to visualize in the rat with MRI either with or without the use of contrast agents. We previously demonstrated that the oral administration of an ultrasmall superparamagnetic iron oxide (AMI-227) produces a brightening of the lumen of the GI tract with a T1-weighted spin-echo pulse sequence. We have also shown that AMI-227 darkens abdominal lymph nodes. In the present study we show that the combined oral and intravenous administration of AMI-227 produces a brightening of the lumen of the GI tract and a darkening of the superior mesenteric lymph node chain. As a result of these combined and opposing effects on image signal intensity, a necessary contrast is established to reliably locate the superior mesenteric lymph nodes in vivo, which, to our knowledge, have been elusive by other techniques.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7854022     DOI: 10.1016/0730-725x(94)90081-2

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  2 in total

1.  USPIO-enhanced MRI for preoperative staging of gynecological pelvic tumors: preliminary results.

Authors:  Thomas M Keller; Sven C A Michel; Johannes Fröhlich; Daniel Fink; Rosmarie Caduff; Borut Marincek; Rahel A Kubik-Huch
Journal:  Eur Radiol       Date:  2004-02-26       Impact factor: 5.315

2.  Ferumoxytol-enhanced magnetic resonance imaging methodology and normal values at 1.5 and 3T.

Authors:  Colin G Stirrat; Shirjel R Alam; Thomas J MacGillivray; Calum D Gray; Rachael Forsythe; Marc R Dweck; John R Payne; Sanjay K Prasad; Mark C Petrie; Roy S Gardner; Saeed Mirsadraee; Peter A Henriksen; David E Newby; Scott I K Semple
Journal:  J Cardiovasc Magn Reson       Date:  2016-07-27       Impact factor: 5.364

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.